Home/Filings/4/0000899243-22-014412
4//SEC Filing

Giffin Brett A. 4

Accession 0000899243-22-014412

CIK 0001492674other

Filed

Apr 10, 8:00 PM ET

Accepted

Apr 11, 9:38 AM ET

Size

4.4 KB

Accession

0000899243-22-014412

Insider Transaction Report

Form 4
Period: 2022-04-08
Giffin Brett A.
Chief Commercial Officer
Transactions
  • Purchase

    Common Stock

    2022-04-08$0.49/sh+10,600$5,18310,600 total

Issuer

T2 Biosystems, Inc.

CIK 0001492674

Entity typeother

Related Parties

1
  • filerCIK 0001892921

Filing Metadata

Form type
4
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 9:38 AM ET
Size
4.4 KB